PFX:NASDAQPhenixFIN Corporation Analysis
Data as of 2026-04-24 - not real-time
$39.81
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The stock is trading below its short‑term and intermediate moving averages, with the 20‑day SMA under the 50‑day and 200‑day levels, signaling a bearish momentum. The MACD histogram is negative and the signal line is bearish, while the RSI sits in a neutral zone, offering little upside momentum. Volume has been trending down, and the 30‑day volatility is elevated, suggesting price swings may continue.
Fundamental backdrop: The company reports a negative profit margin and operating cash flow deficits, coupled with a very high debt‑to‑equity ratio, which raises concerns about financial stability. However, the price‑to‑book ratio is well below one, indicating the market is pricing the equity at a discount to its book value. The forward earnings estimate is positive, but current earnings are negative, and there is no dividend history. Recent news highlights that the stock slipped below a key trend level, drawing attention from insiders and institutional investors, which could add short‑term pressure.
Fundamental backdrop: The company reports a negative profit margin and operating cash flow deficits, coupled with a very high debt‑to‑equity ratio, which raises concerns about financial stability. However, the price‑to‑book ratio is well below one, indicating the market is pricing the equity at a discount to its book value. The forward earnings estimate is positive, but current earnings are negative, and there is no dividend history. Recent news highlights that the stock slipped below a key trend level, drawing attention from insiders and institutional investors, which could add short‑term pressure.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish technical indicators (price below key moving averages, negative MACD)
- Decreasing volume and high short‑term volatility
- Negative earnings and cash flow pressure
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential price appreciation if market re‑prices book value
- Forward earnings outlook turning positive
- Continued financial strain from high leverage
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant discount to book value offering upside potential
- Asset‑backed portfolio may generate stable returns over time
- Improved earnings trajectory expected as investments mature
Key Metrics & Analysis
Financial Health
Revenue Growth7.10%
Profit Margin-11.98%
P/E Ratio18.8
ROE-1.93%
ROA3.19%
Debt/Equity95.64
P/B Ratio0.5
Op. Cash Flow$-3097083
Free Cash Flow$-1014604
Industry P/E17.3
Technical Analysis
TrendBearish
RSI42.3
Support$38.30
Resistance$42.54
MA 20$40.42
MA 50$41.64
MA 200$44.86
MACDBearish
VolumeDecreasing
Fear & Greed Index88.02
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta-0.13
Volatility29.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.